-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2024.
- Transcode Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 14.7M shares, a 13322% increase year-over-year.
- Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 179K shares, a 1003% increase from 2022.
- Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 16.2K shares, a 99.8% decline from 2021.
- Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 8.43M shares, a 81.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)